FEV(1) Minimum Important Difference versus Minimal Detectable Difference? In Search of the Unicorn

por Crim, Courtney, Frith, Lucy J., Midwinter, Dawn, Donohue, James F.
Publicado 2021

Circulating neutrophils levels are a predictor of pneumonia risk in chronic obstructive pulmonary disease

por Pascoe, Steven J., Papi, Alberto, Midwinter, Dawn, Lettis, Sally, Barnes, Neil
Publicado 2019

The distribution of blood eosinophil levels in a Japanese COPD clinical trial database and in the rest of the world

por Barnes, Neil, Ishii, Takeo, Hizawa, Nobuyuki, Midwinter, Dawn, James, Mark, Hilton, Emma, Jones, Paul W
Publicado 2018

Validation of the Summit Lab Score in Predicting Exacerbations of Chronic Obstructive Pulmonary Disease Among Individuals with High Arterial Stiffness

por Horne, Benjamin D, Ali, Rehan, Midwinter, Dawn, Scott-Wilson, Catherine, Crim, Courtney, Miller, Bruce E, Rubin, David B
Publicado 2021

Critical Error Frequency and the Impact of Training with Inhalers Commonly used for Maintenance Treatment in Chronic Obstructive Pulmonary Disease

por Collier, David J, Wielders, Pascal, van der Palen, Job, Heyes, Logan, Midwinter, Dawn, Collison, Kathryn, Preece, Andy, Barnes, Neil, Sharma, Raj
Publicado 2020

A randomized, open-label, single-visit, crossover study simulating triple-drug delivery with Ellipta compared with dual inhaler combinations in patients with COPD

por van der Palen, Job, Moeskops-van Beurden, Wendy, Dawson, Carolyn M, James, Wai-Yee, Preece, Andrew, Midwinter, Dawn, Barnes, Neil, Sharma, Raj
Publicado 2018

Clinical effectiveness of once-daily fluticasone furoate/umeclidinium/vilanterol in usual practice: the COPD INTREPID study design

por Worsley, Sally, Snowise, Neil, Halpin, David M.G., Midwinter, Dawn, Ismaila, Afisi S., Irving, Elaine, Sansbury, Leah, Tabberer, Maggie, Leather, David, Compton, Chris
Publicado 2019

A randomized trial of once-daily fluticasone furoate/vilanterol or vilanterol versus placebo to determine effects on arterial stiffness in COPD

por Bhatt, Surya P, Dransfield, Mark T, Cockcroft, John R, Wang-Jairaj, Jie, Midwinter, Dawn A, Rubin, David B, Scott-Wilson, Catherine A, Crim, Courtney
Publicado 2017

INTREPID: single- versus multiple-inhaler triple therapy for COPD in usual clinical practice

por Halpin, David M.G., Worsley, Sally, Ismaila, Afisi S., Beeh, Kai-Michael, Midwinter, Dawn, Kocks, Janwillem W.H., Irving, Elaine, Marin, Jose M., Martin, Neil, Tabberer, Maggie, Snowise, Neil G., Compton, Chris
Publicado 2021

Cost-Effectiveness of Single- versus Multiple-Inhaler Triple Therapy in a UK COPD Population: The INTREPID Trial

por Halpin, David M G, Kendall, Robyn, Shukla, Soham, Martin, Alan, Shah, Dhvani, Midwinter, Dawn, Beeh, Kai M, Kocks, Janwillem W H, Jones, Paul W, Compton, Chris, Risebrough, Nancy A, Ismaila, Afisi S
Publicado 2022

Effect of Recent Exacerbation History on the Efficacy of Once-Daily Single-Inhaler Fluticasone Furoate/Umeclidinium/Vilanterol Triple Therapy in Patients with Chronic Obstructive P...

por Panettieri Jr, Reynold A, Camargo Jr, Carlos A, Cheema, Tariq, El Bayadi, Sherif G, Fiel, Stanley, Vila, Tania M, Jain, Renu G, Midwinter, Dawn, Thomashow, Byron, Ludwig-Sengpiel, Andrea, Lipson, David A
Publicado 2022

Time‐Dependent Risk of Cardiovascular Events Following an Exacerbation in Patients With Chronic Obstructive Pulmonary Disease: Post Hoc Analysis From the IMPACT Trial

por Dransfield, Mark T., Criner, Gerard J., Halpin, David M. G., Han, MeiLan K., Hartley, Benjamin, Kalhan, Ravi, Lange, Peter, Lipson, David A., Martinez, Fernando J., Midwinter, Dawn, Singh, Dave, Wise, Robert, Kunisaki, Ken M.
Publicado 2022

Effect of chronic mucus hypersecretion on treatment responses to inhaled therapies in patients with chronic obstructive pulmonary disease: Post hoc analysis of the IMPACT trial

por Thompson, Philip J., Criner, Gerard J., Dransfield, Mark T., Halpin, David M. G., Han, MeiLan K., Lipson, David A., Maghzal, Ghassan J., Martinez, Fernando J., Midwinter, Dawn, Singh, Dave, Tombs, Lee, Wise, Robert A.
Publicado 2022

Discordant diagnostic criteria for pneumonia in COPD trials: a review

por Wise, Robert A., Bafadhel, Mona, Crim, Courtney, Criner, Gerard J., Day, Nicola C., Halpin, David M.G., Han, MeiLan K., Lange, Peter, Lipson, David A., Martinez, Fernando J., Maselli, Diego J., Midwinter, Dawn, Singh, Dave, Zysman, Maeva, Dransfield, Mark T., Russell, Richard E.K.
Publicado 2021

Reduction in All-Cause Mortality with Fluticasone Furoate/Umeclidinium/Vilanterol in Patients with Chronic Obstructive Pulmonary Disease

por Lipson, David A., Crim, Courtney, Criner, Gerard J., Day, Nicola C., Dransfield, Mark T., Halpin, David M. G., Han, MeiLan K., Jones, C. Elaine, Kilbride, Sally, Lange, Peter, Lomas, David A., Lettis, Sally, Manchester, Pamela, Martin, Neil, Midwinter, Dawn, Morris, Andrea, Pascoe, Steven J., Singh, Dave, Wise, Robert A.
Publicado 2020